BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
41 results:

  • 1. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
    Karimpour M; Totonchi M; Behmanesh M; Montazeri H
    Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancer.
    Wei Y; Zhang L; Wang C; Li Z; Luo M; Xie G; Yang X; Li M; Ren S; Zhao D; Gao R; Gong JN
    Animal Model Exp Med; 2023 Jun; 6(3):245-254. PubMed ID: 37271936
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Discovery of novel VEGFR-2-PROTAC degraders based on the localization of lysine residues via recruiting vhl for the treatment of gastric cancer.
    Wang XR; Wang S; Mu HX; Xu KY; Wang XT; Shi JT; Cui QH; Zhang LW; Chen SW
    Eur J Med Chem; 2022 Dec; 244():114821. PubMed ID: 36242985
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy.
    Huh YJ; Cho SY; Cho MS; Lee KE; Lee JH
    Genes Genomics; 2022 Nov; 44(11):1425-1435. PubMed ID: 35622232
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical considerations for the design of PROTACs in cancer.
    Nieto-Jiménez C; Morafraile EC; Alonso-Moreno C; Ocaña A
    Mol Cancer; 2022 Mar; 21(1):67. PubMed ID: 35249548
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The First Case of gastric Neuroendocrine Tumors Induced by a Proton Pump Inhibitor in von Hippel-Lindau Disease.
    Kawaguchi K; Yashima K; Ikebuchi Y; Yoshida A; Kuwamoto S; Isomoto H
    Intern Med; 2022 Sep; 61(17):2587-2592. PubMed ID: 35135919
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/vhl/HIF1α/VEGFA pathway.
    Du Y; Zhang JY; Gong LP; Feng ZY; Wang D; Pan YH; Sun LP; Wen JY; Chen GF; Liang J; Chen JN; Shao CK
    Cancer Lett; 2022 Feb; 526():259-272. PubMed ID: 34863886
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
    Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
    J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2.
    Du G; Jiang J; Wu Q; Henning NJ; Donovan KA; Yue H; Che J; Lu W; Fischer ES; Bardeesy N; Zhang T; Gray NS
    Angew Chem Int Ed Engl; 2021 Jul; 60(29):15905-15911. PubMed ID: 33915015
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Magnetically Controlled Capsule Endoscopy Versus Conventional Gastroscopy: A Systematic Review and Meta-Analysis.
    Geropoulos G; Aquilina J; Kakos C; Anestiadou E; Giannis D
    J Clin Gastroenterol; 2021 Aug; 55(7):577-585. PubMed ID: 33883514
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
    Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
    BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
    Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ancestry-specific predisposing germline variants in cancer.
    Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
    Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1α.
    Liu D; Li H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988076
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
    Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
    Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genomic landscape of pancreatic neuroendocrine tumours: the International cancer Genome Consortium.
    Mafficini A; Scarpa A
    J Endocrinol; 2018 Mar; 236(3):R161-R167. PubMed ID: 29321190
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Von Hippel-Lindau Disease With Multi-Organ Involvement: A Case Report and 8-Year Clinical Course With Follow-Up.
    Yaghobi Joybari A; Azadeh P
    Am J Case Rep; 2017 Nov; 18():1220-1224. PubMed ID: 29146893
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
    Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy.
    de Haas S; Delmar P; Bansal AT; Moisse M; Miles DW; Leighl N; Escudier B; Van Cutsem E; Carmeliet P; Scherer SJ; Pallaud C; Lambrechts D
    Angiogenesis; 2014 Oct; 17(4):909-20. PubMed ID: 25012543
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.